GHK-Cu is a copper-binding tripeptide complex composed of the amino acid sequence glycyl-L-histidyl-L-lysine (GHK) coordinated with a copper ion (Cu²⁺). It has been discussed in scientific literature for its relevance to peptide–metal interactions and cellular signaling mechanisms.

In controlled laboratory research environments, GHK-Cu has been studied in connection with skin-associated biological models, collagen-related signaling pathways, and extracellular matrix (ECM) research frameworks. Research interest has focused on its role within cellular communication systems, gene expression modeling, and copper-dependent biochemical processes under in-vitro and analytical conditions.

These investigations are conducted to better understand how copper-binding peptides interact with cellular and structural pathways, rather than to evaluate cosmetic, therapeutic, or physiological outcomes.

Any references to skin biology, collagen-associated pathways, or cellular structure are provided solely for educational and laboratory context and do not imply therapeutic, cosmetic, regenerative, or clinical effects.

Theramedix GHK-Cu is produced to strict research-grade purity and handling standards for biochemical and molecular investigation only.

This material is provided exclusively for laboratory research, analytical study, and in-vitro investigation.
Not for human or veterinary use. For research use only.